22-49883795-G-A
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_014838.3(ZBED4):c.133G>A(p.Glu45Lys) variant causes a missense change. The variant allele was found at a frequency of 0.0000285 in 1,613,396 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014838.3 missense
Scores
Clinical Significance
Conservation
Publications
- ALG12-congenital disorder of glycosylationInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, G2P, ClinGen, Labcorp Genetics (formerly Invitae), PanelApp Australia, Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZBED4 | ENST00000216268.6 | c.133G>A | p.Glu45Lys | missense_variant | Exon 2 of 2 | 1 | NM_014838.3 | ENSP00000216268.4 | ||
ZBED4 | ENST00000850559.1 | c.133G>A | p.Glu45Lys | missense_variant | Exon 2 of 2 | ENSP00000520851.1 | ||||
ZBED4 | ENST00000850560.1 | n.260+317G>A | intron_variant | Intron 2 of 3 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152172Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000796 AC: 2AN: 251372 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.0000287 AC: 42AN: 1461224Hom.: 0 Cov.: 29 AF XY: 0.0000372 AC XY: 27AN XY: 726756 show subpopulations
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152172Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74350 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.133G>A (p.E45K) alteration is located in exon 2 (coding exon 1) of the ZBED4 gene. This alteration results from a G to A substitution at nucleotide position 133, causing the glutamic acid (E) at amino acid position 45 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at